Clinical indications for therapeutic drug monitoring of antifungal agents. In the way for optimizing the treatment of fungal infection

被引:0
|
作者
Cendejas-Bueno, Emilio [1 ]
Cuenca-Estrella, Manuel [1 ]
Gomez-Lopez, Alicia [1 ]
机构
[1] Inst Salud Carlos III, Ctr Nacl Microbiol, Microbiol Serv, Majadahonda 28220, Madrid, Spain
关键词
serum concentrations; Voriconazole; Posaconazole; Itraconazole; PERFORMANCE-LIQUID-CHROMATOGRAPHY; CELL TRANSPLANT RECIPIENTS; SOLID-PHASE EXTRACTION; LC-MS/MS METHOD; ITRACONAZOLE SERUM CONCENTRATIONS; HYDROXYPROPYL-BETA-CYCLODEXTRIN; REFERENCE LABORATORY EXPERIENCE; COLUMN-SWITCHING TECHNIQUE; TANDEM MASS-SPECTROMETRY; HIGH-DOSE FLUCONAZOLE;
D O I
暂无
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Therapeutic drug monitoring as a tool in the management of infectious diseases has been introduced in therapy with anti-infective agents for years. Nowadays, it has taken importance in the management of fungal diseases due to the appearance of new antifungal drugs such as new-generation azoles. These azoles have pharmacokinetic characteristics that hinder a proper use to ensure efficacy and minimize toxicity. Monitoring of serum concentrations may help in the better use of these anti-infective agents, as well as in a better management of drug interactions, infectious disease and adverse effects. It has resulted in saving costs of treatment and in avoiding inadequate dosages. This review will attempt to clarify the role of the antifungal agents Therapeutic Drug Monitoring, highlighting the role of azole compounds.
引用
收藏
页码:1 / 16
页数:16
相关论文
共 50 条
  • [31] Spotlight commentary: The role of therapeutic drug monitoring in optimizing treatment with antipsychotic medicines
    Nina, Jelcic
    Robert, Likic
    Mara, Tripkovic
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 90 (12) : 3084 - 3086
  • [32] Drug Clues for the Treatment of Fungal Catheter-Related Bloodstream Infection With Antifungal Lock Therapy
    Li, Xiuyun
    Yu, Bing
    Li, Hui
    Liu, Zhirui
    Fu, Xiaohan
    Jiao, Ping
    Wang, Lei
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2025, 19 : 683 - 701
  • [33] Therapeutic strategy for invasive fungal infection in neutropenic patients in clinical haematology: retrospective analysis of antifungal prescriptions
    Aurelie, Terrier-Lenglet
    Tayeb, Chouaki
    Catherine, Haegel
    Patrick, Votte
    Jean-Pierre, Marolleau
    Ioana, Vaida
    MYCOSES, 2011, 54 : 104 - 104
  • [34] Implementation and outcomes of a therapeutic drug monitoring program for antifungal and antiretroviral agents in a tertiary medical center in Taiwan
    Lin, Shu-Wen
    Kuo, Ching-Hua
    Shen, Li-Jiuan
    Chen, Yee-Chun
    Hung, Chien-Ching
    Wu, Fe-Lin Lin
    JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, 2020, 3 (05): : 905 - 912
  • [35] Recommendations for Optimizing Tuberculosis Treatment: Therapeutic Drug Monitoring, Pharmacogenetics, and Nutritional Status Considerations
    Choi, Rihwa
    Jeong, Byeong-Ho
    Koh, Won -Jung
    Lee, Soo-Youn
    ANNALS OF LABORATORY MEDICINE, 2017, 37 (02) : 97 - 107
  • [36] Optimizing the dose of mycophenolate mofetil for the maintenance treatment of lupus nephritis by therapeutic drug monitoring
    A. Zabotti
    M. Baraldo
    L. Quartuccio
    S. Sacco
    G. De Marchi
    S. De Vita
    Clinical Rheumatology, 2015, 34 : 171 - 174
  • [37] Optimizing the dose of mycophenolate mofetil for the maintenance treatment of lupus nephritis by therapeutic drug monitoring
    Zabotti, A.
    Baraldo, M.
    Quartuccio, L.
    Sacco, S.
    De Marchi, G.
    De Vita, S.
    CLINICAL RHEUMATOLOGY, 2015, 34 (01) : 171 - 174
  • [38] Mucormycosis: A hidden mystery of fungal infection, possible diagnosis, treatment and development of new therapeutic agents
    Hussain, Mohd Kamil
    Ahmed, Shaista
    Khan, Andleeb
    Siddiqui, Arif Jamal
    Khatoon, Shahnaaz
    Jahan, Sadaf
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 246
  • [39] Fungal biomarkers, antifungal susceptibility testing, and therapeutic drug monitoring-practical applications for the clinician in a tertiary care center
    Amsden J.R.
    Current Fungal Infection Reports, 2015, 9 (2) : 111 - 121
  • [40] Addressing current medical needs in invasive fungal infection prevention and treatment with new antifungal agents, strategies and formulations
    Pitman, Stuart K.
    Drew, Richard H.
    Perfect, John R.
    EXPERT OPINION ON EMERGING DRUGS, 2011, 16 (03) : 559 - 586